Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 1608
New York, New York 10022
July 11, 2019
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Pharmaceuticals Holding Corp.|
Registration Statement on Form S-1 (File No. 333-232195)
Ladies and Gentlemen:
Tonix Pharmaceuticals Holding Corp. hereby requests that its acceleration request dated July 9, 2019 be withdrawn.
Please call Steven M. Skolnick of Lowenstein Sandler LLP at (973) 597-2476 with any questions.
|Very truly yours,|
|TONIX PHARMACEUTICALS HOLDINGS CORP.|
|By:||/s/ Bradley Saenger|
|Title:||Chief Financial Officer|